nature.com
Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial - Nature Communications
Persistent cardiac symptoms are common in post-COVID syndrome. In the Myoflame-19 trial, losartan plus prednisolone yielded neutral results for the primary outcome, change in left ventricular ejection...